Keyphrases
Chronic Lymphocytic Leukemia Cells
100%
Chronic Lymphocytic Leukemia
95%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
69%
Acute Myeloid Leukemia
38%
Overall Survival
32%
Signal Transducer and Activator of Transcription 3
25%
Chronic Myeloid Leukemia
24%
Leukemia Patients
20%
Prognostic Factors
20%
Prognostic Indicator
18%
Cyclophosphamide
18%
Leukemia
17%
Israel
16%
Methotrexate
16%
Hematopoietic Cell Transplantation
15%
Gene mutation
15%
MicroRNA
15%
Glioblastoma
15%
Autologous Transplantation
14%
Apoptosis
14%
Infectious Complications
14%
Tyrosine Kinase Inhibitor
14%
Patient Survival
14%
Multiple Myeloma
14%
Febrile Neutropenia
14%
B Cell Receptor
14%
Allogeneic
13%
Fludarabine
13%
Single-center Experience
13%
Diffuse Large B-cell Lymphoma (DLBCL)
13%
Risk Factors
13%
Expression Level
13%
Clinical Significance
12%
Relapsed or Refractory
12%
Chemoimmunotherapy
12%
Acute Leukemia
12%
Complete Remission
12%
Long QT Syndrome
12%
Myelodysplastic Syndrome
12%
Survival Benefit
12%
Tumor
12%
IGHV mutation
12%
Long QT Syndrome Type 3
12%
Serological Response
12%
Ranolazine
12%
BNT162b2 Vaccine
12%
Methotrexate Treatment
12%
Premature Aging
12%
Pentraxin 3 (PTX3)
12%
Primary Myelofibrosis
12%
Medicine and Dentistry
B-Cell Chronic Lymphocytic Leukemia
93%
Leukemia Cell
54%
Hematopoietic Stem Cell
48%
Cell Transplantation
41%
Acute Myeloid Leukemia
31%
Chronic Myelogenous Leukemia
24%
Methotrexate
24%
Overall Survival
23%
Tyrosine-Kinase Inhibitor
20%
Gene Mutation
18%
Diffuse Large B-Cell Lymphoma
18%
Neoplasm
15%
Prognostic Factor
14%
Infectious Complication
14%
Transplantation
14%
Hematologic Malignancy
13%
Disease
13%
Leukemia
12%
Acute Leukemia
12%
Janus Kinase
12%
Ectopic Pregnancy
12%
Multiple Myeloma
12%
Conception
12%
Allogeneic Hematopoietic Stem Cell Transplantation
12%
Observational Study
12%
Monoclonal Antibody
12%
Antiinfective Agent
12%
Graft Versus Host Reaction
12%
STAT3 Protein
12%
Diagnosis
12%
Febrile Neutropenia
10%
Infection
10%
Clinical Trial
10%
Protein Expression
10%
Rituximab
10%
Drug Megadose
10%
Multivariate Analysis
10%
Signal Transduction
9%
Prevalence
9%
Metastatic Carcinoma
9%
Glioblastoma
9%
Interleukin-6
9%
B Lymphocyte Receptor
8%
Programmed Cell Death
8%
Engraftment
8%
Platelet
8%
Small Interfering RNA
8%
Surgical Technique
7%
Acute Lymphoblastic Leukemia
7%
Ruxolitinib
7%